Differential diagnosis of temporomandibular disorders and other orofacial pain disorders.
Jeffrey P Okeson, Reny de Leeuw
https://pubmed.ncbi.nlm.nih.gov/21094721Actively Recruiting
Led by University of Coimbra · Updated on 2025-02-13
40
Participants Needed
1
Research Sites
21 weeks
Total Duration
Temporomandibular disorder (TMD) includes musculoskeletal conditions affecting the jaw joint, chewing muscles, and nearby structures. About 30 to 40% of acute painful TMD cases become chronic, causing ongoing pain that affects daily life, emotional well-being, and quality of life. Chronic orofacial pain involves complex biological and psychological factors, making treatment challenging. This trial investigates the effectiveness of transcranial magnetic stimulation (TMS), a non-invasive brain stimulation method, in treating chronic TMD pain and aims to identify predictors of treatment success using brain connectivity and psychosocial assessments. Participants receive either active or sham repetitive transcranial magnetic stimulation (rTMS) over the motor cortex. The active rTMS is applied at 10Hz with 2000 pulses per session at 90% of the resting motor threshold, using a figure-8 coil. Ten sessions are conducted, spaced between 24 to 72 hours apart. The sham treatment mimics the look and sound of rTMS without delivering magnetic pulses. This randomized, triple-blinded trial compares these two groups to assess rTMS effects on chronic TMD. Participants will be assessed for pain intensity and jaw function before and after all rTMS sessions, with follow-ups at one week, two weeks, and one month post-treatment. Additional evaluations include pain-related disability, depression, anxiety, central sensitization, quality of life, and brain functional connectivity at various time points during and after treatment. The study tracks changes across these measures to understand the impact and safety of rTMS in chronic TMD over the course of treatment and follow-up periods.
CONDITIONS
Efficacy of Repetitive Transcranial Magnetic Stimulation in Temporomandibular Disorders.
You may qualify if you...
You will not qualify if you...
Complete this quick 3-step screening to check your eligibility
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
screening and enrollment visit
Duration - 10 sessions with a minimum interval of 24 hours and a maximum of 72 hours between sessions
Participants receive repetitive transcranial magnetic stimulation (rTMS) over the motor cortex with either active or sham device sessions.
10 visits (in-person) for device sessions
Duration - 1 month after treatment completion
Participants are monitored for changes in pain intensity, functional limitation, and other secondary outcomes after treatment.
3 visits at 1 week, 2 weeks, and 1 month after treatment
Total: 1 location
1
University of Coimbra
Coimbra, Portugal, 3000-548
Actively Recruiting
M
Miguel Castelo-Branco
C
Catarina Duarte
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Jeffrey P Okeson, Reny de Leeuw
https://pubmed.ncbi.nlm.nih.gov/21094721Eric Schiffman, Richard Ohrbach, Edmond Truelove...
https://pubmed.ncbi.nlm.nih.gov/24482784A Lövgren, B Häggman-Henrikson, C M Visscher...
https://pubmed.ncbi.nlm.nih.gov/26311138Peter Rammelsberg, Linda LeResche, Samuel Dworkin...
https://pubmed.ncbi.nlm.nih.gov/12756926Steven P Cohen, Jianren Mao
https://pubmed.ncbi.nlm.nih.gov/24500412Yuanyuan Yin, Shushu He, Jingchen Xu...
https://pubmed.ncbi.nlm.nih.gov/32560622Raphael Freitas de Souza, Claudia H Lovato da Silva, Mona Nasser...
https://pubmed.ncbi.nlm.nih.gov/22513948Charles S Greene, Daniele Manfredini
https://pubmed.ncbi.nlm.nih.gov/33966303Neil E O'Connell, Louise Marston, Sally Spencer...
https://pubmed.ncbi.nlm.nih.gov/29547226Natália R Ferreira, Ygor N Junqueira, Nathália B Corrêa...
https://pubmed.ncbi.nlm.nih.gov/31415654